“⚕베스트토토검증【평생베스트.com】베스트토토놀이터⚕”的搜索结果，显示 311-320 项，共有 14579 项

1. NF2-related schwannomatosis (neurofibromatosis type 2) - 诊断与治疗- 妙佑医疗国际

   ... best protect hearing and nerve function. Our caring team of Mayo Clinic experts can help you with your nf2-related schwannomatosis (neurofibromatosis type 2)- ...

2. 血液科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this study is to correlate gut microbiome with specific cancer diagnoses and the ...

3. 血液科- 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma. First In Human Study Of TORL-1-23 In Participants ...

8. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to: Evaluate the influence of the critical shoulder angle (CSA) on outcomes after total anatomic shoulder arthroplasty; and ...

9. 泌尿科- 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...